Dr Karl-Heinz Altmann

Dr Karl-Heinz Altmann serves as Full Professor of Pharmaceutical Sciences at ETH Zurich and he is also the current Head of the Department of Chemistry & Applied Biosciences at ETH Zurich. Prior to re-joining academia at ETH Zurich in 2003, Prof. Altmann gained 13 years of industry experience as a chemist and group leader at Ciba-Geigy and Novartis Pharma. In 2017, he co-founded Tolremo Therapeutics AG and was previously awarded the Paul Ehrlich Prize of the Société de Chimie Thérapeutique, France, in 2014.